Jean-Louis Boulay
Department of Biomedicine
University Hospital
Basel
Switzerland
Name/email consistency: high
- Loss of heterozygosity of TRIM3 in malignant gliomas. Boulay, J.L., Stiefel, U., Taylor, E., Dolder, B., Merlo, A., Hirth, F. BMC. Cancer (2009)
- The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomas. Boulay, J.L., Ionescu, M.C., Sivasankaran, B., Labuhn, M., Dolder-Schlienger, B., Taylor, E., Morin, P., Hemmings, B.A., Lino, M.M., Jones, G., Maier, D., Merlo, A. Int. J. Oncol. (2009)
- SMAD7 is a prognostic marker in patients with colorectal cancer. Boulay, J.L., Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U., Herrmann, R., Rochlitz, C. Int. J. Cancer (2003)
- Molecular phylogeny within type I cytokines and their cognate receptors. Boulay, J.L., O'Shea, J.J., Paul, W.E. Immunity (2003)
- SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Boulay, J.L., Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U., Herrmann, R., Rochlitz, C. Br. J. Cancer (2002)
- Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7. Boulay, J.L., Mild, G., Reuter, J., Lagrange, M., Terracciano, L., Lowy, A., Laffer, U., Orth, B., Metzger, U., Stamm, B., Martinoli, S., Herrmann, R., Rochlitz, C. Genes. Chromosomes. Cancer (2001)
- Web alert. Environmental biotechnology. Regulatory affairs. Boulay, J.L., Miot, S. Curr. Opin. Biotechnol. (2001)
- Protein technologies and commercial enzymes. Web alert. Boulay, J.L., Miot, S. Curr. Opin. Biotechnol. (2000)
- Chemical biotechnology pharmaceutical biotechnology. Web alert. Boulay, J.L., Miot, S. Curr. Opin. Biotechnol. (2000)
- Web alert. Pharmaceutical biotechnology. Chemical biotechnology. Boulay, J.L. Curr. Opin. Biotechnol. (1999)